Jin Medical International Ltd.
ZJYL
$0.6407
-$0.0019-0.30%
NASDAQ
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | 22.62% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | 22.62% | |||
| Cost of Revenue | 0.00% | 5.52% | |||
| Gross Profit | 0.00% | 53.07% | |||
| SG&A Expenses | 0.00% | 30.14% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 0.00% | -24.26% | |||
| Total Operating Expenses | 0.00% | 12.95% | |||
| Operating Income | 0.00% | 96.03% | |||
| Income Before Tax | 0.00% | 7.80% | |||
| Income Tax Expenses | 0.00% | 47.18% | |||
| Earnings from Continuing Operations | 0.00% | 0.65% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 0.00% | 85.30% | |||
| Net Income | 0.00% | 4.89% | |||
| EBIT | 0.00% | 96.03% | |||
| EBITDA | 0.00% | 87.31% | |||
| EPS Basic | 0.00% | 5.26% | |||
| Normalized Basic EPS | 0.00% | 13.95% | |||
| EPS Diluted | 0.00% | 5.26% | |||
| Normalized Diluted EPS | 0.00% | 13.95% | |||
| Average Basic Shares Outstanding | 0.00% | 0.09% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.09% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||